|
 Lash Group is a pioneer in designing solutions to reimbursement-related issues for pharmaceutical companies, medical device manufacturers, biotechnology firms, and payers. For more than a decade, clients grappling with these challenges have turned to us for customized approaches based on our broad range of consulting, reimbursement support, and web-based services.
Lash Group's core strength is designing solutions for clients facing unique challenges associated with marketing new and existing pharmaceutical, medical technology, and biotech products.
Our problem-solving approach—grounded in expertise in strategic planning, reimbursement consulting, and patient management services—is bolstered by web-based capabilities and customized systems integration. These skills—coupled with an integrated team of health care consultants who design, launch, and manage all engagements—assure clients of seamless service delivery.
Founded in 1986 as a privately held health care consulting firm, Lash Group launched our reimbursement consulting and services practice for pharmaceutical and biotech companies in 1990. Our capabilities were expanded in 1998 when we became a business unit of AmerisourceBergen
Corporation (NYSE: ABC), the largest pharmaceutical services company in the United States. Today we operate as an autonomous business unit within the AmerisourceBergen
Specialty Group. Under AmerisourceBergen's acquisition of US Bioservices Corporation in January 2003, Lash Group integrated operations and services with the former firm Documedics, based in California. We now operate as one company under the Lash Group name, with expanded services offered through our Charlotte, San Francisco, Phoenix, and Washington, DC offices.
AmerisourceBergen (NYSE:
ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital systems and acute care market, alternate care facilities, independent community pharmacies, and regional chain pharmacies. AmerisourceBergen is also a leader in the institutional pharmacy marketplace. With more than $54 billion in annualized operating revenue, AmerisourceBergen is headquartered in Valley Forge, Pennsylvania, and employs more than 13,000 people. AmerisourceBergen is ranked #27 on the Fortune 500 list.
As part of the AmerisourceBergen Specialty Group, Lash Group is able to provide clients with seamless, integrated specialty distribution and other services. Our sister companies include Integrated Commercialization Solutions (ICS), ASD Specialty Healthcare, Besse Medical Supply, and Oncology Supply. The AmerisourceBergen Specialty Group offers comprehensive services across the entire product continuum, from pre-launch strategies to commercialization, distribution, and market expansion.
|
